The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bruce who is a Dreamer? If I have got sarossa wrong that is my mistake. The point I was trying to make is RG has a holding, held by entities under his control, within a whisker of the required bid.
Whose a pain??
Forgive me, is the minimum price mentioned the highest price he (his group) have paid. Or the highest price paid by anyone, in the previous 12 months.
These dreamers are a pain. Sarossa is a biotech company quoted Otc in USA. Looks like fun brewing
jh you are correct RG controls Blake Holding, Serendipity, Sarossa etc. It is his TOTAL control.
Pity those on another board who were adamant he was a Forced Seller over there, don't do proper research.
. Absolute tosh. These boards do have some clowns.
On the last RNS it shows him as 9.27 and the other companies etc making up the difference to 29%. These guys certainly spin a wide web. They all add , not just Circassia,their wives grannies children and the pet dog so it doesn’t come up as them owning so many shares.
last RNS showed "Griffiths and controlled undertakings" moving from 28.61% to 29.83%.
If that makes it clearer I honestly dont know lol
market watch shows Richard Isn Griffiths 28.6% holder in own name
Oh, got that wrong, the crafty man, he holds 9.2% but has control through his other companies amounting to 29% .
hope so !!
I think/ hope action is imminent. I topped up this morning in my account and my wifes pension. If this goes wrong she will kill me lol
Think it’s the highest price the share achieved over the last 12 months not the highest price he paid. :)
agreed...he will make an offer soon. His Directors knew that when they bought recently. They must be expecting a worthwhile profit ...so I am guessing we will get a healthy premium. Lowest he can offer is the highest he has paid in the last 12 months I believe
So downside is limited...and directors bought expecting a quick profit. What should an investor do when the house is playing with its cards face up I ask lol?
Grif has 29% of the companies shares(voting rights) if he passes 30% he is obliged under rule 9?
To make an offer for all shareholders shares at the highest price over the last 12 months.
What makes you say that ?
Now very close to takeover.
Nice adjustment of third party involvement,
Yes. Good indications which will backstop their Option positions which have a trigger of 62.5p. Per previous posts, historic senior management never bought any of the stock with own funds and relied on freebie gimme options. This is an excellent indication of new teams direction, realism, and most of all professionalism.
Yup. Moving up on the news. I just want to dig and check there are no short term price triggers for Exec bonus awards. I just have a very suspicious mind......but hopefully it’s nothing more than they see it as a good deal....
Nice to see rns large director purchases presumably embargoed until last week announcement
Good to see large bod share purchases today. They probably were embargoed untilmladt weeks announcement.
https://masterinvestor.co.uk/equities/small-cap-round-up-featuring-circassia-severfield-medica-and-more/
40p initial target
This resolution will pass with out any issue.
No I didn’t know. Thanks foe enlightening me.
SK do you realy think CIR would put a proposal to shareholders if AZ have not agreed? No the BOD would be incompetent to take such a course of action.
Question, as I don’t know. Would their be any problem with the proposal from AstraZeneca .
Or can they ( Circassia ) just go ahead with shareholders approval and terminate the agreement.
Per my previous posts, CIR did not have the rights of AZ products outside of US, and I had suggested we had to wait and see if they could pull something off here against the embedded behemoths of GSK and BI to name but two. The AZ products are good ones but unfortunately they arrived a little to late to the COPD party and simply don't have the scale to succeed. Covid19 may actually prove a positive outcome for them to allow the return of rights of AZ. And so CIR for now becomes solely focussed on NioX and its FeNO operations, CIR having decided to 'write off' its respiratory technology acquisition Prosonix a while back too, and its allergy technology suffering a spectacular fail. It has essentially become a beefed up Aerocrine, the Swedish company it bought at the same times as Prosonix in 2015. Debt free is good, but whether the broker rerates are sufficiently attractive to see a material uptick in share price remains to be seen. Of worthy note in the RNS is that the performance conditions for the management new PSP based incentives still have the 62p trigger. We need to give IJ a chance and trust they can deliver. Watch out for Broker rerates in the first instance. Taking profits as and when you can in the mean time is IMHO a reasonably strategy, particularly if it goes past 30p.